Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.45
-0.35-1.61%
Last update: 1:45 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Pharvaris Stock Price, Quotes and Forecasts | NASDAQ:PHVS | Benzinga
Explore Pharvaris stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHVS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pharvaris (PHVS) stock?
You can purchase shares of Pharvaris (NASDAQ:PHVS) through any online brokerage.
Who are Pharvaris (PHVS) competitors?
Other companies in Pharvaris’s space includes: Atai Beckley (NASDAQ:ATAI), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).
What is the forecast, or price target, for Pharvaris (PHVS) stock?
Pharvaris has a consensus price target of $37.64.
What is the current price for Pharvaris (PHVS)?
The stock price for Pharvaris (NASDAQ: PHVS) is $21.45 last updated November 7, 2025 at 1:45 PM EST.
Does Pharvaris (PHVS) pay a dividend?
There are no upcoming dividends for Pharvaris.
When is Pharvaris (NASDAQ:PHVS) reporting earnings?
Pharvaris’s Q3 earnings are confirmed for Friday, November 21, 2025.
Is Pharvaris (PHVS) going to split?
There is no upcoming split for Pharvaris.
What sector and industry does Pharvaris (PHVS) operate in?
Pharvaris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
